[
  {
    "ts": null,
    "headline": "AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine",
    "summary": "AbbVie is expected to beat Q4 2024 revenue and EPS estimates. Check out why I rate ABBV stock as a buy.",
    "url": "https://finnhub.io/api/news?id=e783ab9060f8fa331f8339ed926b062ab76517b4128338cc587b4e62ece70bf1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737876295,
      "headline": "AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine",
      "id": 132473443,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1724371368/image_1724371368.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie is expected to beat Q4 2024 revenue and EPS estimates. Check out why I rate ABBV stock as a buy.",
      "url": "https://finnhub.io/api/news?id=e783ab9060f8fa331f8339ed926b062ab76517b4128338cc587b4e62ece70bf1"
    }
  },
  {
    "ts": null,
    "headline": "The Week Ahead",
    "summary": "The Week Ahead",
    "url": "https://finnhub.io/api/news?id=776391aecaed88be39b503aa2ce418e21848846c9af7c30556f617d88d397983",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737873052,
      "headline": "The Week Ahead",
      "id": 132473236,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=776391aecaed88be39b503aa2ce418e21848846c9af7c30556f617d88d397983"
    }
  }
]